They also hint at a previously unappreciated but potentially crucial role for LRRK2 in regulating the central nervous system immune milieu in PD patients (Patrick et al., 2019) via alteration of mitochondrial homeostasis in brain-resident glial cells. This evidence concerns the gene LRRK2 and Parkinson disease.